| Term 
 | Definition 
 
        | decreases hepatic glucose production, increases peripheral insulin sensitivity in fat and muscle tissues, and decreases intestinal absorption of glucose |  | 
        |  | 
        
        | Term 
 
        | Second Generation Sulfonylureas |  | Definition 
 
        | block ATP-sensitive potassium-channels on pancreatic beta cells --> decreases potassium outflow--> stimulates insulin release |  | 
        |  | 
        
        | Term 
 
        | Meglitinides/Phenylalanines |  | Definition 
 
        | block ATP-sensitive potassium-channels on pancreatic beta cells --> decreases potassium outflow --> stimulates insulin release (same MOA as sulfonylureas!) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | bind peroxisome proliferator activated receptor (PPAR-gamma) --> increase skeletal muscle insulin sensitivity and decrease hepatic produciton of glucose and free fatty acids |  | 
        |  | 
        
        | Term 
 
        | Dipeptidyl Peptidase-4 (DDP-IV) Inhibitors |  | Definition 
 
        | inhibits DDP-IV to increase levels of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) leading to: increased insulin secretion, decreased hepatic glucose production, and delayed gastric emptying |  | 
        |  | 
        
        | Term 
 
        | Alpha-Glucosidase Inhibitors |  | Definition 
 
        | inhibits intestinal alpha-glucosidase hydrolase and pancreatic alpha-amylase resulting in delayed carbohydrate absorption |  | 
        |  | 
        
        | Term 
 
        | Glucagon-Like Peptide-1 (GLP-1) Agonists |  | Definition 
 
        | Increases glucose-dependent insulin secretion, decreases glucagon secretion, decreases hepatic glucose production, delays gastric emptying, and increases satiety |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | binds bile acids within intestine, thereby impeding their biliary reabsorption; the mechanism by which fasting plasma glucose and A1c are reduced are unknown |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | exact mechanism in the improvement of glycemic control is unknown; may reset hypothalamic circadian rhythms which can improve postprandial glucose concnetrations without increasing plasma insulin concentrations |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | co-secreted with insulin from pancreatic beta cells; decreases glucagon secretion, decreases hepatic glucose production, delays gastric emptying, and increases satiety |  | 
        |  |